Certain thalassemic human 0-globin pre-mRNAs carry mutations that generate aberrant splice sites and/or activate cryptic splice sites, providing a convenient and clinically relevant system to study splice site selection. Antisense 2'-O-methyl oligoribonucleotides were used to block a number of sequences in these pre-mRNAs and were tested for their ability to inhibit splicing in vitro or to affect the ratio between aberrantly and correctly spliced products. By this approach, it was found that (i) up to 19 nucleotides upstream from the branch point adenosine are involved in proper recognition and functioning of the branch point sequence; (ii) whereas at least 25 nucleotides of exon sequences at both 3' and 5' ends are required for splicing, this requirement does not extend past the 5' splice site sequence of the intron; and (iii) improving the 5' splice site of the internal exon to match the consensus sequence strongly decreases the accessibility of the upstream 3' splice site to antisense 2'-O-methyl oligoribonucleotides. This result most likely reflects changes in the strength of interactions near the 3' splice site in response to improvement of the 5' splice site and further supports the existence of communication between these sites across the exon.Pre-mRNA splicing takes place within a large ribonucleoprotein complex termed the spliceosome. The specificity and accuracy of splicing are determined by the interactions of small nuclear ribonucleoprotein particles and protein components of the spliceosome with a number of pre-mRNA sequence elements in pre-mRNA, such as the branch point sequence, the polypyrimidine tract, and the 3' and 5' splice sites (reviewed in references 15, 21, and 29). In addition, exon sequences seem to contribute to the specificity of splicing (references 35, 41, and 49 and references therein). However, besides identification of a regulatory element in the female-specific exon of the doublesex pre-mRNA (17,19,30) and characterization of purinerich motifs in exons from some other spliced transcripts (7,12,27,45,47,49,51), the involvement of exon sequences in splicing remains unclear.In this work, we have used antisense 2'-O-methyl oligoribonucleotides (see reference 43 for a review) to study the function of several intron and exon sequences in pre-mRNA splicing. This approach stems from our recent report which showed that the binding of 2'-O-methyl oligoribonucleotides to the branch point or aberrant splice sites leads to the restoration of correct in vitro splicing of mutated P-globin premRNAs identified in individuals with various forms of 3-thalassemia (11). These oligonucleotides form strong duplexes with RNA which are resistant to RNase H and RNA unwinding activities. In consequence, they remain stably associated with the complementary regions in RNA, efficiently inhibiting the function of the targeted sequences. Antisense 2'-O-methyl oligoribonucleotides were originally used as sequence-specific probes to study the structure of small nuclear ribonucleoproteins and their interactions w...